Chemplast Sanmar Limited
NSE: CHEMPLASTS · Specialty Chemicals · sector
Key numbers
Last 12 months to Jun 2026, Consolidated. "Sector median" = middle value of 107 companies in Specialty Chemicals (P/E median leaves out loss-making companies). Tap ? for what a number means.
Things to know
- Cash ₹533 cr vs borrowings ₹1,952 cr (FY26): borrowings are higher by ₹1,419 cr.
- Borrowings rose in each of the last 3 years (₹1,008 cr → ₹1,952 cr).
- Operating profit covered interest -1.2x in the last 12 months.
- Operating cash flow was below net profit in 1 of the last 5 years (FY24).
- Net loss in 8 of the last 8 quarters.
- Revenue was higher than a year earlier in 3 of the last 4 quarters.
- Debtor days went from 18 (FY24) to 8 (FY26).
- No dividend in the last 5 financial years.
- Price ₹190.27 on 2026-10-26: -53.9% from the 52-week high, +18.2% from the 52-week low.
Plain facts from the filings, built by the same fixed rules for every company. A line appears only when the data for it is available. Not a view on the stock.
Charts
Quarterly results
| ₹ cr | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 993 | 1,058 | 1,151 | 1,100 | 1,033 | 835 | 1,256 | 1,125 |
| EBITDA | 26 | 32 | 37 | 17 | 43 | -57 | 44 | -115 |
| OPM % | 2.6% | 3.0% | 3.2% | 1.6% | 4.2% | -6.8% | 3.5% | -10.2% |
| Other income | 11 | 11 | 14 | 9 | 7 | 5 | 7 | 3 |
| Net profit | -31 | -49 | -54 | -64 | -51 | -119 | -45 | -176 |
| EPS (₹) | -1.95 | -3.06 | -3.39 | -4.02 | -3.21 | -7.45 | -2.87 | -11.10 |
| Revenue YoY | +4.1% | -21.0% | +9.1% | +2.3% | ||||
| Profit YoY | – | – | – | – |
Consolidated figures where filed. Latest quarter Jun 2026.
Profit & loss (yearly)
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 | TTM |
|---|---|---|---|---|---|---|
| Revenue | 5,892 | 4,941 | 3,923 | 4,346 | 4,224 | 4,249 |
| EBITDA | 1,197 | 388 | 26 | 219 | 48 | -84 |
| Net profit | 649 | 152 | -158 | -110 | -280 | -391 |
| EPS (₹) | 43.66 | 9.64 | -10.02 | -6.92 | -17.70 | -24.63 |
| Revenue growth | -16.1% | -20.6% | +10.8% | -2.8% | -1.2% | |
| Profit growth | -76.5% | -203.6% | – | – | – | |
| Dividend / share (₹) | – | – | – | – | – |
| Compounded growth | 3 years | 5 years | Last 12 months |
|---|---|---|---|
| Sales | -5.1% | – | -1.2% |
| Net profit | – | – | – |
| EPS | – | – | – |
| Share price | – | -36.5% (2y) | -51.0% |
Balance sheet
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Shareholders' equity | – | 1,858 | 1,701 | 2,068 | 1,755 |
| Borrowings | – | 1,008 | 1,542 | 1,841 | 1,952 |
| Cash & equivalents | – | 1,192 | 801 | 724 | 533 |
| Total assets | – | 5,837 | 6,030 | 6,503 | 6,315 |
| Fixed assets | – | 3,186 | 3,907 | 4,493 | 4,382 |
| Capital work in progress | – | 402 | 190 | 137 | 341 |
| Investments | – | 0 | 0 | 0 | 8 |
| Receivables | – | 143 | 190 | 155 | 92 |
| Inventory | – | 643 | 569 | 657 | 602 |
| Payables | – | 1,862 | 1,746 | 1,667 | 1,637 |
Year-end figures from the March annual filing.
Cash flow
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Cash from operations | 901 | 355 | -245 | 172 | 294 |
| Cash from investing | 108 | -217 | -524 | -407 | -232 |
| Cash from financing | -313 | -27 | 382 | 66 | -187 |
| Capex | 112 | 420 | 619 | 382 | 316 |
| Free cash flow | 788 | -64 | -864 | -211 | -22 |
Free cash flow = cash from operations − capex.
Ratios by year
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| ROE % | – | 8.2% | -9.3% | -5.3% | -16.0% |
| ROCE % | – | 11.4% | -1.4% | 1.7% | -3.7% |
| Debtor days | – | 11 | 18 | 13 | 8 |
| Inventory days | – | 73 | 77 | 87 | 82 |
| Payable days | – | 212 | 235 | 221 | 224 |
| Cash conversion cycle (days) | – | -128 | -140 | -121 | -134 |
| Working capital days | – | -5 | -56 | -79 | -126 |
Shareholding
| Holder | % (2026-09-30) |
|---|---|
| Promoters | 54.99% |
| FIIs | 10.66% |
| DIIs | 22.41% |
| of which Mutual funds | 21.37% |
| of which Insurance | 0.81% |
| Public (non-institutions) | 11.94% |
| Quarter | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters % | 54.99% | 54.99% | 54.99% | 54.99% | 54.99% | 54.99% | 54.99% | 54.99% |
| Promoter group | % |
|---|---|
| Sanmar Holdings Limited | 54.99% |
| Kulathu Venkatasubramanian | 0.00% |
| Mahadevan Raman | 0.00% |
| Satya Narayan Nayak | 0.00% |
| Natarajan Muralidharan | 0.00% |
| Pallikondan Vedachalam Sriram | 0.00% |
| Sanmar Chemical Enterprises Limited | 0.00% |
| Sanmar Group International Limited | 0.00% |
| TCI Sanmar Chemicals S.A.E , Egypt | 0.00% |
| Sanmar Overseas Investments AG , Switzerland | 0.00% |
| Vibrant Trading SG PTE Ltd, Singapore | 0.00% |
| Public holders above 1% | % |
|---|---|
| SBI Small CAP Fund | 9.73% |
| Amansa Holdings Private Limited | 7.62% |
| ICICI Prudential Energy Opportunities Fund | 5.19% |
| Axis Mutual Fund Trustee Limited A/C Axis Mutual F | 3.67% |
| Franklin India Small CAP Fund | 2.36% |
65,455 shareholders. Pledged: – of promoter shares.
Peers in Specialty Chemicals
| Company | Market cap | P/E | P/B | ROE | ROCE | OPM | Sales 3y | Div yield |
|---|---|---|---|---|---|---|---|---|
| PIDILITIND | ₹1,50,431 cr | 56.8x | 13.9x | 25.7% | 33.4% | 24.5% | +7.4% | 1.01% |
| FLUOROCHEM | ₹46,168 cr | 75.4x | 5.9x | 8.1% | 10.0% | 25.6% | -4.2% | 0.07% |
| NAVINFLUOR | ₹39,306 cr | 49.7x | 9.9x | 23.9% | 22.2% | 33.7% | +16.8% | 0.18% |
| DEEPAKNTR | ₹19,676 cr | 25.1x | 3.4x | 14.0% | 15.3% | 15.4% | -0.4% | 0.52% |
| AETHER | ₹19,529 cr | 82.8x | 8.0x | 10.1% | 11.4% | 30.9% | +21.2% | – |
| ATUL | ₹15,762 cr | 19.8x | 2.5x | 11.9% | 16.9% | 17.9% | +7.9% | 0.47% |
| AARTIIND | ₹15,539 cr | 29.3x | 2.6x | 9.2% | 8.0% | 14.9% | +7.8% | 0.24% |
| FINEORG | ₹15,328 cr | 35.0x | 5.8x | 17.7% | 21.3% | 21.7% | -7.8% | 0.22% |
| BASF | ₹13,174 cr | 20.5x | 3.3x | 16.9% | 22.0% | 5.9% | +3.1% | 0.66% |
| CHEMPLASTS | ₹3,009 cr | – | 1.7x | -20.5% | -7.6% | -2.0% | -5.1% | – |
Business segments (FY26)
| Segment | Revenue | Share | EBIT | Margin |
|---|---|---|---|---|
| Commodity | ₹2,262 cr | 51.0% | ₹-104 cr | -4.6% |
| Specialities | ₹2,170 cr | 49.0% | ₹-34 cr | -1.6% |
Documents
- Annual report FY26
- Annual report FY25
- Annual report FY24
- Annual report FY23
- Annual report FY22
- Announcements NSE filings
- BRSR FY26
- Latest results (data file) XBRL
- Announcements BSE filings
Links go to the original files on the exchange website.
About the company
- Basic Chemical Elements: Manufacture and sale of Speciality PVC Resin, Caustic Soda, Custom manufactured chemicals, Chloromethanes, Refrigerant gases, Hydrogen peroxide.
- Organic and inorganic chemical compounds not elsewhere classified: Manufacture and sale of Speciality PVC Resin, Caustic Soda, Custom manufactured chemicals, Chloromethanes, Refrigerant gases, Hydrogen peroxide.
- Manufacture of liquefied or compressed inorganic industrial or medical gases (elemental gases, liquid or compressed air, refrigerant gases, mixed industrial gases): Manufacture and sale of Speciality PVC Resin, Caustic Soda, Custom manufactured chemicals, Chloromethanes, Refrigerant gases, Hydrogen peroxide.
- Others: Manufacture and sale of Speciality PVC Resin, Caustic Soda, Custom manufactured chemicals, Chloromethanes, Refrigerant gases, Hydrogen peroxide.
| Sector | Commodities |
| Industry | Specialty Chemicals |
| Sub-industry | Specialty Chemicals |
| Symbol | CHEMPLASTS |
| BSE code | 543336 |
| ISIN | INE488A01050 |
| Face value | ₹5.0 |
| Incorporated | 1985-03-13 |
| Website | www.chemplastsanmar.com |
| Plants (India / abroad) | 5 / 0 |
From the company's filings (BRSR FY26).
Data built 2026-10-23 from NSE company filings (XBRL: Integrated Filing - Financials + financial results), NSE shareholding & pledge data; price = NSE close 2026-10-26.